Stock Price Quote

DHAMPUR BIO ORGANICS LTD.

NSE : DBOLBSE : 543593ISIN CODE : INE0I3401014Industry : SugarHouse : Private
BSE97.45-1.8 (-1.81 %)
PREV CLOSE ( ) 99.25
OPEN PRICE ( ) 98.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3457
TODAY'S LOW / HIGH ( )96.45 99.60
52 WK LOW / HIGH ( )58.3 115
NSE97.42-1.88 (-1.89 %)
PREV CLOSE( ) 99.30
OPEN PRICE ( ) 98.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 215445
TODAY'S LOW / HIGH( ) 96.74 100.19
52 WK LOW / HIGH ( )57.34 115.25
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 26-10 2020
Management Info
Vijay Kumar Goel - Chairman Gautam Goel - Managing Director
Registered Office

Address Sugar Mill Compound,Village & Post - Asmoli,District - Sambhal,
Moradabad,
Uttar Pradesh-244304

Phone 7302318313

Email investors@dhampur.com

Website www.dhampur.com

Registrars Details
Alankit Assignments Ltd.
Alankit House , 4 E/2,Jhandewala Extension,,New Delhi
Listing : BSE, NSE

NEWS

27Feb Dhampur Bio Organics gains on getting
Dhampur Bio Organics is currently trading at Rs. 103.25, up by 1.75 poin..
26Feb Dhampur Bio Organics gets nod to incor
Dhampur Bio Organics has received approval to incorporation a wholly own..
13Nov Dhampur Bio Organics informs about ou
Pursuant to the provisions of the Regulation 33 of SEBI (Listing Obligat..
02Aug Dhampur Bio Organics informs about boa
Pursuant to Regulation 30 read with clause 8 of Para B of Part A of Sche..
28Jul Dhampur Bio Organics informs about out
Dhampur Bio Organics has informed that the Board of Directors at its Mee..

Financials

in Millions
QTR Dec 25 ANNUAL 25
Net Profit138.700000000001120.899999999998
Gross Profit 214.900000000001 178.399999999998
Operating Profit 473.7000000000011436.4
Net Sales 7054.327144

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Godavari Biorefin (BSE)
peergroup  292.75 (3.68%)
M.Cap ( in Cr)1498.18
Avadh Sugar & Energy (BSE)
peergroup  410.25 (0.98%)
M.Cap ( in Cr)821.26
SBEC Sugar (BSE)
peergroup  29.29 (2.88%)
M.Cap ( in Cr)139.58
Parvati Sweetners (BSE)
peergroup  7.75 (2.92%)
M.Cap ( in Cr)115.59
Gayatri Sugars (BSE)
peergroup  7.65 (0.92%)
M.Cap ( in Cr)56.84

Shareholding Pattern

PROMOTERS 50.65%
NON-INSTITUTION 48.1%
FI/BANKS/INSURANCE 0.45%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Dhampur Bio Organics Ltd.

Dhampur Bio Organics Ltd. was incorporated in the year 2020. Its today's share price is 97.45. Its current market capitalisation stands at Rs 646.95 Cr. In the latest quarter, company has reported Gross Sales of Rs. 27144 Cr and Total Income of Rs.18866.7 Cr. The company's management includes Kishor Shah, Samir Thukral, Vishal Saluja, Ruchika Mehra Kothari, Bindu Vashist Goel, Sandeep Kumar, Gautam Goel, Ashwani Kumar Gupta, Vijay Kumar Goel, Ashu Rawat.

It is listed on the BSE with a BSE Code of 543593 , NSE with an NSE Symbol of DBOL and ISIN of INE0I3401014. It's Registered office is at Sugar Mill Compound,Village & Post - Asmoli,District - SambhalMoradabad-244304, Uttar Pradesh. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Mittal Gupta & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.